Ad
related to: moderna
Search results
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 2 days agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 5 days agoModerna (NASDAQ: MRNA) jumped into the limelight when it started developing a coronavirus vaccine candidate. And the stock soared as the vaccine raced...
FDA Approves Moderna’s mRESVIA Vaccine | JD Supra
JD Supra· 1 day agoOn May 31, 2024, Moderna announced that the FDA has approved its respiratory syncytial virus vaccine (“RSV”), mRESVIA (mRNA-1345). The vaccine...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 4 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 5 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 5 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 2 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...
New COVID variant KP.3 climbs to 25%, now largest in CDC estimates
CBS News· 1 day agoThe new KP.3 variant has climbed to 1 in 4 new COVID-19 cases nationwide, the Centers for Disease...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 4 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 5 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...